Skip to main content
Clinical Trials/CTIS2022-501549-57-00
CTIS2022-501549-57-00
Recruiting
Phase 1

Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren Contracture Affecting the Metacarpophalangeal Joint. A Randomized Controlled Trial. - 2022-985

Regionshospitalet Horsens0 sites400 target enrollmentAugust 2, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Dupuytren Concrature
Sponsor
Regionshospitalet Horsens
Enrollment
400
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 2, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Regionshospitalet Horsens

Eligibility Criteria

Inclusion Criteria

  • \>\= 45 years, DC of \= 20° passive extension deficit (PED) in MCP joint measured with a finger goniometer, DC of either II\-V finger, Well\-defined/palpable cord, Received oral and written information of the trial prior to inclusion, Willingness to participate and signed written informed patient consent form

Exclusion Criteria

  • Legally incapacitated, Rheumatoid arthritis, Amyloidosis or mucopolysaccharidosis, Unable to communicate, cooperate or participate in follow\-up, Unable to speak or read Danish language, Previous study inclusion with another finger ray, Isolated PIP or DIP joint contracture, defined as MCP joint contracture \< 20° PED regardless of the deficit in the PIP or DIP joint, Previous hand surgery of the affected finger for any reason, Known allergy to the study medication, Anticoagulant therapy (Acetylsalicylic acid is NOT an exclusion criterion), Pregnant or lactation, Insulin dependent diabetes mellitus, Ongoing systemic infection or local infection at the site of the procedure

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Percutaneous needle fasciotomy versus limited fasciectomy in Dupuytren's diseaseDupuytren's diseaseMusculoskeletal DiseasesFibroblastic disorders
ISRCTN58554745niversity Medical Centre Groningen (UMCG) (Netherlands)120
Active, not recruiting
Phase 1
eedling in patients with tennis elbowateral Elbow Tendinopathy is a common cause for chronic pain in the elbow, where the pain is present for longer than 6 months. Currently, the rationale is that the tendinopathy is the result of the repetitive strain of the hand, wrist and elbow.Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2018-002822-22-NLSint Maartenskliniek114
Recruiting
Not Applicable
S-guided Percutaneous needle tenotomy in Patients with Lateral Elbow Tendinopathy: A multicenter Randomized Controlled Triallateral elbow tendinopathytenniselbow10043237
NL-OMON46011Sint Maartenskliniek15
Completed
Phase 4
Injection with corticosteroids in the sulcus of the elbow (with ultrasound) in patients with an ulnar neuropathy and EMG abnormalitiescompression ulnar neuropathyirritated nerve at the elbow10034606
NL-OMON33011Medisch Centrum Haaglanden90
Active, not recruiting
Phase 1
The Soft Tissue Injection of Corticosteroid and Local Anaesthetic StudyTrigger fingerDe Quervains tenosynovitisCarpal tunnel syndromeMedDRA version: 21.0Level: PTClassification code 10044654Term: Trigger fingerSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2019-003742-32-GBniversity Hospitals Plymouth NHS Trust100